Our Stories

What might look like an ordinary wreath displayed at our U.S. headquarters is a powerful symbol of our collective hope and united purpose—to serve patients with compassion.

As a physician and drug developer, Marielle Cohard-Radice, MD has experienced many challenging opportunities throughout her career that have informed her agile approach to leading during times of change.

Daiichi Sankyo and Sarah Cannon Research Institute (SCRI) announced a strategic collaboration with a goal to work together to accelerate the development of new medicines to improve the standard of care for patients with cancer.

Fay Dunbar, Director of Inclusion & Diversity shares what led her to this work and her vision for an equitable workplace

Partnering with the Oncology Community for Progress

Our Leaders of Innovation: Ken Takeshita, MD

Michele Schmidt, RN, has held in her 20-year plus career in oncology drug development bringing new and innovative medicines to patients

Thanks to our veterans contributing to Daiichi Sankyo’s global mission— to contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs.

Prior to his career in drug development, Eric Richards, MS, MPH spent a decade training as a ‘triple threat’ in the performing arts -- acting, singing, and dancing – before specializing in classical vocal music.

Our dedicated advocacy partners are hard at work developing solutions and providing resources to help these patients, and at Daiichi Sankyo, we share their commitment.

At Daiichi Sankyo, we are invested in addressing complex challenges across the clinical trial process.

Our 2022 internship class shares experiences, lessons learned and motivations for a future in healthcare after a summer with Daiichi Sankyo

At Daiichi Sankyo, we believe compassion grows from understanding that no two people suffering from a condition are alike. Each cancer patient has their own set of experiences, challenges and perspectives — a unique story to tell.

Addressing the gaps in this underutilized but critical component of comprehensive cancer screening

During Pride Month, Daiichi Sankyo commemorates the progress that has been made for equal justice under the law for the LGTBQ+ community, while acknowledging that there is more work to be done to raise awareness and encourage inclusiveness.

For Daiichi Sankyo, ASCO22 was historic as we demonstrated our bold leadership in oncology with numerous advances across our ADC portfolio.

At Daiichi Sankyo we proudly observe Asian Pacific American Heritage Month (APAHM) in May. During this month, we recognize our own Asian heritage—Daiichi Sankyo is a global company based in Japan with more than 100 years of history in medical science.

Each spring, we’re tickled pink about the role one of our first leaders played in bringing Japanese cherry trees to the U.S. Capital over 110 years ago.

Lauren and Jennifer are among the 50 mentees who participated in the inaugural year of the Daiichi Sankyo, Inc. Women’s Forum Mentorship Program.

This Rare Disease Day, we hope you will join us in supporting the millions of people across the rare disease community by raising awareness of the resources, programs and support available at rarediseaseday.org.

This February 4, it’s critical for everyone around the globe to come together for World Cancer Day to raise awareness, improve education and spur action around inequities in cancer care.

As we prepare to celebrate the birthday of Dr. Martin Luther King, Jr., we are taking time to reflect on his life and legacy as a man who sowed the seeds of healing in America.

As we enter Lung Cancer Awareness Month (LCAM) and Gastric (Stomach) Cancer Awareness Month (GCAM) this November, we are putting a spotlight on the importance of biomarker testing.

Breast Cancer Awareness Month (BCAM) is synonymous with education and exchanging information about the disease, its impact and ways to detect and manage it.

Approximately every three minutes, one person in the U.S. is diagnosed with blood cancer. September is Blood Cancer Awareness Month, a time to show our support for these patients and raise awareness of ongoing research to help fight the disease.